Notice Pursuant to the National Cooperative Research and Production Act of 1993GE Corporate Research and Development: Bulk Gallium Nitride and Homoepitaxial Device Manufacturing

[Federal Register Volume 64, Number 231 (Thursday, December 2, 1999)]
[Notices]
[Page 67589]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-31259]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--GE Corporate Research and Development: Bulk 
Gallium Nitride and Homoepitaxial Device Manufacturing

    Notice is hereby given that, on August 6, 1999, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), GE Corporate Research and 
Development has filed written notifications simultaneously with the 
Attorney General and the Federal Trade Commission disclosing (1) the 
identities of the parties and (2) the nature and objectives of the 
venture. The notifications were filed for the purpose of invoking the 
Act's provisions limiting the recovery of antitrust plaintiffs to 
actual damages under specified circumstances. Pursuant to Section 6(b) 
of the Act, the identities of the parties are GE Corporate Research and 
Development, a division of General Electric Company, Niskayuna, NY; and 
Sanders, a division of Lockheed Martin Corporation, Nashua, NH. The 
nature and objectives of the venture are to conduct research on Bulk 
Gallium Nitride (GaN) and Homoepitaxial Device manufacturing. The 
activities of this joint venture will be partially funded by an award 
from the Advanced Technology Program, National Institute of Standards 
and Technology, Department of Commerce.
Constance K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 99-31259 Filed 12-1-99; 8:45 am]
BILLING CODE 4410-11-M